Financials
- Market Capitalization 436.18 M
- Employee 48
- Founded 2020
- CEO N/A
- Website www.evommune.com
- Headquarter Delaware, United States
- FIGI BBG00Y79N887
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-1.53
Relación precio/flujo de caja
8.08
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3007 | SGMT Sagimet Biosciences Inc. - Series A Common Stock | 7.15 USD | -2.99% | -7.74% | +8.99% | -23.94% | 441.53 M USD | ||
| 3012 | SLN Silence Therapeutics Plc - American Depository Share | 9.29 USD | +2.20% | -12.44% | +36.82% | +46.99% | 438.81 M USD | ||
| 3022 | CCCC C4 Therapeutics, Inc. - Common Stock | 3.92 USD | -3.45% | -5.54% | -1.51% | +64.71% | 433.42 M USD | ||
| 3037 | ASMB Assembly Biosciences, Inc. - Common Stock | 26.96 USD | -1.61% | -7.03% | +13.90% | -8.38% | 428.46 M USD |